GlaxoSmithKline Announces Commencement of Eltrombopag Phase III Worldwide Clinical Trial in Adults With Previously-Treated Idiopathic Thrombocytopenic Purpura
London, England and Philadelphia, Pennsylvania (ots/PRNewswire) - GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated ...
mehr